Glaxosmithkline Consumer Healthcare is currently trading at Rs. 7130.00, up by 94.15 points or 1.34% from its previous closing of Rs. 7035.85 on the BSE.
The scrip opened at Rs. 7144.00 and has touched a high and low of Rs. 7165.60 and Rs. 7100.00 respectively.
The BSE group ‘A’ stock of face value Rs. 10 has touched a 52 week high of Rs. 7934.85 on 18-Dec-2018 and a 52 week low of Rs. 5850.00 on 14-May-2018.
Last one week high and low of the scrip stood at Rs. 7165.60 and Rs. 6905.00 respectively. The current market cap of the company is Rs. 30048.68 crore.
The promoters holding in the company stood at 72.46%, while Institutions and Non-Institutions held 11.49% and 16.05% respectively.
Glaxosmithkline Consumer Healthcare has reported a rise of 34.94% in its net profit at Rs 285.81 crore for the quarter under review as compared to Rs 211.81 crore for the same quarter in the previous year. Total income of the company increased by 11.49% at Rs 1408.95 crore for Q4FY19 as compared Rs 1,263.75 crore for the corresponding quarter previous year.
For the year ended March 31, 2019, the company has reported a rise of 40.38% in its net profit at Rs 982.80 crore as compared to Rs 700.10 crore for the previous year. Total income of the company increased by 12.52% at Rs 5214.61 crore for year under review as compared to Rs 4634.46 crore for year ended March 31, 2018.
The post Glaxosmithkline Consumer Healthcare soars on reporting 35% rise in Q4 net profit appeared first on Udaipur News | Udaipur Latest News | udaipur local news.
